Navigation Links
Actos Lawsuit Filed By Wright & Schulte on Behalf of Ohio Man Alleges Extended Use of Type-2 Diabetes Drug Caused Him to Develop Bladder Cancer
Date:9/10/2013

Columbus, OH (PRWEB) September 10, 2013

The Actos lawsuit lawyers at Wright & Schulte LLC have recently filed an Actos lawsuit on behalf of an Ohio man. This #Actos lawsuit (Case No. 2013L005092, Consolidated Case No. 2011 L 10011) was filed on May 16, 2013 in the Circuit Court of Cook County, Illinois and names Takeda Pharmaceuticals, Inc. as the defendant. According to the complaint, this Actos lawsuit alleges that the plaintiff’s use of Actos diabetes medication for more than 12 months led to him developing bladder cancer and that Takeda knew of the risks of Actos bladder cancer and failed to warn the public about these risks.

Wright & Schulte, LLC specializes in defending the rights of those who have sustained serious injuries after using dangerous medications. Our skilled Actos bladder cancer attorneys are experienced at successfully going up against large corporations like Takeda Pharmaceuticals, Inc. We encourage those who believe they have developed bladder cancer or other injuries due to the use of Actos to speak with our knowledgeable lawyers by visiting yourlegalhelp.com or by calling 1-800-399-0795.

Court documents for this case explain that the plaintiff was prescribed Actos in April 2011 for the treatment of his type-2 diabetes. After regularly taking Actos for more than one year, in August 2012, the plaintiff was diagnosed with bladder cancer. Although the plaintiff stopped taking Actos a few months prior to his bladder cancer diagnosis, after this diagnosis, the plaintiff had to undergo extensive medical treatments – including multiple surgeries and chemotherapy – to treat his bladder cancer. According to the complaint, the plaintiff’s use of Actos for more than one year caused him to develop bladder cancer, which has now left him with permanent, severe injuries that will require long-term medical treatments and that will negatively impact the rest of his life.

Research and Warnings about Actos Bladder Cancer

In 2011, the American Diabetes Association published a study regarding the potential link between Actos (generically known as pioglitazone) and the risk of bladder cancer. After reviewing adverse event reports (AER) associated with Actos that had been filed with the FDA between 2004 and 2009, researchers found that there was a statistically significant increase in the risk of bladder cancer when taking Actos for more than 12 months. In the conclusion of this study, researchers stated that, “[i]n agreement with preclinical and clinical studies, AERS analysis is consistent with an association between pioglitazone and bladder cancer. This issue needs constant epidemiologic surveillance.” [care.diabetesjournals.org/content/34/4/916.full January 2011]

Shortly after the publication of this research, in June 2011, the FDA issued an Actos safety announcement, warning the public that “use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” While the FDA ordered Takeda to update the warning labels on Actos medication to include information about the risk of bladder cancer at this time, it also highlighted in its safety announcement that taking Actos for longer periods of time and taking higher doses of the drug could increase the risk of bladder cancer. Specifically, the FDA pointed out that Actos patients who took the drug for longer than 12 months had about a 40 percent increased risk of developing bladder cancer (when compared to individuals not taking Actos). [fda.gov/Drugs/DrugSafety/ucm259150.htm June 2011]

About Wright & Schulte LLC

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/9/prweb10962615.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Actos Bladder Cancer Lawsuits Move Forward, with Issuance of New Order in Federal Actos Litigation, Bernstein Liebhard LLP Reports
2. Lawsuit Alleges Takeda Pharmaceutical Co., Maker of Diabetes Drug Actos, Didn’t Warn of the Drug’s Risks Soon Enough; Parker Waichman LLP Responds
3. Actos Lawsuit News: Bernstein Liebhard LLP Notes Start of Second Actos Bladder Cancer Trial in Maryland State Court
4. Actos Bladder Cancer Lawsuits Help: Resource4thePeople Reports Number of Consolidated Federal Cases Climbs to over 2,500
5. Actos Lawsuits Move Forward Following Latest Status Conference in Federal Actos Bladder Cancer Litigation
6. Oregon Man Developed Bladder Cancer Brought on by Years of Ingesting Diabetes Drug Actos, Alleges Lawsuit Filed by Parker Waichman LLP
7. Florida Woman Developed Bladder Cancer After Taking Actos to Treat her Type II Diabetes, Alleges Lawsuit Filed by Parker Waichman LLP
8. Years of Ingesting Diabetes Drug Actos Caused Florida Man to Develop Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP
9. Actos Lawsuits Alleging Bladder Cancer Update: Resource4thePeople Reports Judge Continues to Move Multidistrict Litigation Forward
10. Organic Valley Presents Lactose Free Whole Milk and Lactose Free Half & Half
11. Actos Lawsuit – Status Conference Convened in Federal Actos Bladder Cancer Multidistrict Litigation, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield ... credit rating of “A” and its outlook as “stable.” At the same time, the ... have fallen in recent years, dip below “capital adequacy” thresholds required for its strong ...
(Date:4/28/2017)... California (PRWEB) , ... April 28, 2017 , ... ... T8 Direct Replace tubes . These lamps offer an instant energy-saving solution for ... need to rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization ... Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB ...
(Date:4/28/2017)... San Diego, Ca (PRWEB) , ... April 28, 2017 , ... ... the property management industry in the coastal communities. After Tina Howe joined the team, ... healthy and happy employees, honest services at affordable rates, and giving back to the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
(Date:4/20/2017)... 20, 2017 Research and Markets has announced ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ... ... technologies will rise from USD 20 Billion in 2015 to around ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ...
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
Breaking Medicine Technology: